Management commentary

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The clinical models presented by Parker (Chapter 17) and by Ketter and Wang (Chapter 18) are comprehensive, timely, and are a good example of the necessity in evaluating the evidence base (in this case being somewhat limited in relation to Bipolar II disorder or BP II) in juxtaposition with practitioners’ experience in optimising treatment selection. From the standpoint of diagnostic criteria, I look forward to evaluating how these criteria may change, with DSM-V Field Trials for bipolar disorder currently under way. There is increasing recognition of the phenomenological concept of mixed presentations. If DSM-V does change these criteria, it will most assuredly impact on treatment considerations for BP II. The impact would be even greater if the 4-day criterion is waived for hypomania. Such changes would include many current ‘soft bipolar’ conditions into the BP II domain – conditions which have been minimally studied in terms of clinical treatment.

Original languageEnglish (US)
Title of host publicationBipolar II Disorder
Subtitle of host publicationModelling, Measuring and Managing, Second Edition
PublisherCambridge University Press
Pages228-230
Number of pages3
ISBN (Electronic)9781139003315
ISBN (Print)9781107600898
DOIs
StatePublished - Jan 1 2012

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management commentary'. Together they form a unique fingerprint.

  • Cite this

    Frye, M. A. (2012). Management commentary. In Bipolar II Disorder: Modelling, Measuring and Managing, Second Edition (pp. 228-230). Cambridge University Press. https://doi.org/10.1017/CBO9781139003315.023